Back to trial
Eligibility Pre-Screening
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.
Question 1 of 60%